Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF-β1 activation and reduces regulatory ID gene expression

Biological Chemistry

Volumn 393, Issue 12, 2012, Pages 1463-1470

  Notohamiprodjo, Susan ^a   Djafarzadeh, Roghieh ^a   Rieth, Nicole ^a   Hofstetter, Monika ^a   Jaeckel, Carsten ^a   Nelson, Peter J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

DNA array; Matrix metalloproteinases; Pathway mapping; Renal cell carcinoma; TGF 1 proliferation; Tissue inhibitors of metalloproteinase 1 (TIMP 1)

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INHIBITOR OF DIFFERENTIATION PROTEIN; SMAD PROTEIN; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; CELL DIFFERENTIATION; CELL ENGINEERING; CELL PROLIFERATION; CELL SURFACE; CONFERENCE PAPER; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOPTOSIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MATRIX METALLOPROTEINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84869487009     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0188     Document Type: Conference Paper

References (30)

1. Benezra, R., Davis, R.L., Lassar, A., Tapscott, S., Thayer, M., Lockshon, D., and Weintraub, H. (1990). Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann. NY Acad. Sci. 599, 1-11.
2. Catania, J.M., Chen, G., and Parrish, A.R. (2007). Role of matrix metalloproteinases in renal pathophysiologies. Am. J. Physiol. Renal Physiol. 292, F905-911.
3. Cohen, C.D., Grone, H.J., Grone, E.F., Nelson, P.J., Schlondorff, D., and Kretzler, M. (2002). Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int. 61, 125-132.
4. Cohen, C.D., Lindenmeyer, M.T., Eichinger, F., Hahn, A., Seifert, M., Moll, A.G., Schmid, H., Kiss, E., Gr ö ne, E., Gr ö ne, H.J., et al. (2008). Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis. PloS One 3, e2937.
5. Djafarzadeh, R., Mojaat, A., Vicente, A.B., von Luttichau, I., and Nelson, P.J. (2004). Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities. Biol. Chem. 385, 655-663.
6. Djafarzadeh, R., Noessner, E., Engelmann, H., Schendel, D.J., Notohamiprodjo, M., von Luettichau, I., and Nelson, P.J. (2006). GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing. Oncogene 25, 1496-1508.
7. Djafarzadeh, R., Sauter, S., Notohamiprodjo, S., Noessner, E., Goyal, P., Siess, W., W ö rnle, M., Ribeiro, A., Himmelein, S., Sitter, T., et al. (2012). Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells. PloS One 7, e33963.
8. Hagemann, T., Gunawan, B., Schulz, M., Fuzesi, L., and Binder, C. (2001). mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas. Eur. J. Cancer 37, 1839-1846.
9. Kee, B.L. (2009). E and ID proteins branch out. Nat. Rev. Immunol. 9, 175-184.
10. Kessenbrock, K., Plaks, V., and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
11. Klier, C.M., Nelson, E.L., Cohen, C.D., Horuk, R., Schlondorff, D., and Nelson, P.J. (2001). Chemokine-induced secretion of gelatinase B in primary human monocytes. Biol. Chem. 382, 1405-1410.
12. Koopman, G., Reutelingsperger, C.P., Kuijten, G.A., Keehnen, R.M., Pals, S.T., and van Oers, M.H. (1994). Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-1420.
13. Koul, H., Huh, J.S., Rove, K.O., Crompton, L., Koul, S., Meacham, R.B., and Kim, F.J. (2011). Molecular aspects of renal cell carcinoma: a review. Am. J. Cancer Res. 1, 240-254.
14. Li, X., Zhang, Z., Xin, D., Chua, C.W., Wong, Y.C., Leung, S.C., Na, Y., and Wang, X. (2007). Prognostic significance of Id-1 and its association with EGFR in renal cell cancer. Histopathology 50, 484-490.
15. Liang, Y.Y., Brunicardi, F.C., and Lin, X. (2009). Smad3 mediates immediate early induction of Id1 by TGF-β . Cell. Res. 19, 140-148.
16. Lipworth, L., Tarone, R.E., and McLaughlin, J.K. (2006). The epidemiology of renal cell carcinoma. J. Urol. 176 (6 Pt 1), 2353-2358.
17. Moore, C.S. and Crocker, S.J. (2012). An alternate perspective on the roles of TIMPs and MMPs in pathology. Am. J. Pathol. 180, 12-16.
18. Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstr å le, M., Laurila, E., et al. (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273.
19. Ouyang, X.S., Wang, X., Lee, D.T., Tsao, S.W., and Wong, Y.C. (2002). Over expression of ID-1 in prostate cancer. J. Urol. 167, 2598-2602.
20. Padua, D. and Massague, J. (2009). Roles of TGFbeta in metastasis. Cell. Res. 19, 89-102.
21. Perk, J., Iavarone, A., and Benezra, R. (2005). Id family of helix-loophelix proteins in cancer. Nat. Rev. Cancer 5, 603-614.
22. Raggi, M.C., Djafarzadeh, R., Muenchmeier, N., Hofstetter, M., Jahn, B., Rieth, N., and Nelson, P.J. (2009). Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice. Biol. Chem. 390, 893-897.
23. Schoppmann, S.F., Schindl, M., Bayer, G., Aumayr, K., Dienes, J., Horvat, R., Rudas, M., Gnant, M., Jakesz, R., and Birner, P. (2003). Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer 104, 677-682.
24. Siegel, R., Ward, E., Brawley, O., and Jemal, A. (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61, 212-236.
25. Stetler-Stevenson, W. (2008). Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci. Signal 1, re6.
26. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550.
27. Vandeputte, D.A., Troost, D., Leenstra, S., Ijlst-Keizers, H., Ramkema, M., Bosch, D.A., Baas, F., Das, N.K., and Aronica, E. (2002). Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia 38, 329-338.
28. Wilson, J.W., Deed, R.W., Inoue, T., Balzi, M., Becciolini, A., Faraoni, P., Potten, C.S., and Norton, J.D. (2001). Expression of Id helixloop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 61, 8803-8810.
29. Yu, Q. and Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176.
30. Zebedee, Z. and Hara, E. (2001). Id proteins in cell cycle control and cellular senescence. Oncogene 20, 8317-8325.